Zydus Cadila takes a shot at old Hepatitis C injection to treat Covid-19

Ahmedabad-based Zydus has initiated talks with the Department of Biotechnology for a compassionate trial. It is also working with the USFDA to register the drug for “compassionate use programme”. The company has already registered the drug with the Indian drug controller for a trial approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2yrO98S
via IFTTT